India's TDB is supporting Helix Cell Therapeutics to develop an affordable, dual-targeting CAR-T therapy for multiple myeloma ...
Discover how CellResearchCorp pivoted from a biotech winter to a $25 million revenue turnaround in four years by focusing on ...
In a significant step towards strengthening India’s advanced biotechnology and cell therapy ecosystem, the Technology Development Board (TDB), Department of Science & Technology (DST), ...
Explore how Singapore and New Zealand can lead in AI deployment and foster digital economy growth through strategic ...
Singapore-based biotech company CellResearch Corporation (CellResearchCorp) found itself caught in the depths of a biotech ...
The project focuses on developing an innovative dual-targeting CAR-T therapy designed to attack Multiple Myeloma cells through two distinct cancer markers — BCMA (B-cell maturation antigen) and CD19.
Singapore, led by Annalisa Bruno, have created perovskite solar cells that are around 50 times thinner than conventional ...
Advanced GMP-Certified Skincare OEM Solutions Empowering Global Beauty Brands CALIFORNIA, CA, UNITED STATES, May 7, ...
Department of Science and Technology (DST), has entered into an agreement with Helix Cell Therapeutics Private Limited for the development of a novel dual-targeting Chimeric Antigen Receptor (CAR) ...
Prominent young professor becomes doctoral supervisor at leading Chinese research university amid high-level recruitment ...
Imagine a car whose windows and sunroof can help top up its battery while parked under the sun, or a pair of smart glasses whose lenses can harvest light to power built-in electronics.
Issued on behalf of VisionWave Holdings, Inc., Starfighters Space, Inc., Avaí Bio, Inc., Lake Victoria Gold Ltd., and QSE – Quantum Secure ...